NCT00987142View on ClinicalTrials.gov

Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
EPIDERMOLYSIS BULLOSA
Interventions
DRUG

CX501

Cultured chimeric skin

DEVICE

Occlusive non adherent dressing

Application of an occlusive non adherent dressing in the skin donor site

Trial Locations (2)

Unknown

Fundación Mir-Mir, Barcelona

Hospital La Paz, Madrid

All Listed Sponsors
lead

Tigenix S.A.U.

INDUSTRY

NCT00987142 - Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa | Biotech Hunter | Biotech Hunter